SciSparc Ltd. (SPRC)
NASDAQ: SPRC · Real-Time Price · USD
5.70
+0.13 (2.33%)
Mar 9, 2026, 2:07 PM EDT - Market open
SciSparc Revenue
SciSparc had revenue of $1.31M in the twelve months ending September 30, 2025, up 187.98% year-over-year. In the year 2024, SciSparc had annual revenue of $1.31M, down -54.64%.
Revenue (ttm)
$1.31M
Revenue Growth
+187.98%
P/S Ratio
2.46
Revenue / Employee
$653,000
Employees
2
Market Cap
3.22M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSPRC News
- 7 days ago - SciSparc Announces 1-for-9 Reverse Share Split - GlobeNewsWire
- 5 weeks ago - SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA - GlobeNewsWire
- 5 weeks ago - Neurothera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA - TheNewswire
- 6 weeks ago - SciSparc Successfully Completes Acquisition of IP Portfolio, Advances Toward Immediate Commercialization - GlobeNewsWire
- 7 weeks ago - SciSparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity - GlobeNewsWire
- 7 weeks ago - SciSparc Announces Receipt of Nasdaq Notification of Minimum Stockholders' Equity Non-Compliance - GlobeNewsWire
- 2 months ago - Neurothera Labs Announces Results of AGM - TheNewswire
- 2 months ago - SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects - GlobeNewsWire